Hostname: page-component-546b4f848f-bvkm5 Total loading time: 0 Render date: 2023-05-30T21:09:39.368Z Has data issue: false Feature Flags: { "useRatesEcommerce": true } hasContentIssue false

Dietary isohumulones, the bitter components of beer, raise plasma HDL-cholesterol levels and reduce liver cholesterol and triacylglycerol contents similar to PPARα activations in C57BL/6 mice

Published online by Cambridge University Press:  08 March 2007

Yutaka Miura*
Central Laboratories for Key Technology, Kirin Brewery Co. Ltd, 1-13-5 Fukuura, Kanazawa-ku, Yokohamashi, 236-0004, Japan
Mayu Hosono
Central Laboratories for Key Technology, Kirin Brewery Co. Ltd, 1-13-5 Fukuura, Kanazawa-ku, Yokohamashi, 236-0004, Japan
Chiaki Oyamada
Central Laboratories for Key Technology, Kirin Brewery Co. Ltd, 1-13-5 Fukuura, Kanazawa-ku, Yokohamashi, 236-0004, Japan
Hideharu Odai
Central Laboratories for Key Technology, Kirin Brewery Co. Ltd, 1-13-5 Fukuura, Kanazawa-ku, Yokohamashi, 236-0004, Japan
Shinichi Oikawa
Department of Medicine, Nippon Medical School, Tokyo, 113-8603, Japan
Keiji Kondo
Central Laboratories for Key Technology, Kirin Brewery Co. Ltd, 1-13-5 Fukuura, Kanazawa-ku, Yokohamashi, 236-0004, Japan
*Corresponding author: Dr Yutaka Miura, fax +81 45 788 4042, email
Rights & Permissions[Opens in a new window]


HTML view is not available for this content. However, as you have access to this content, a full PDF is available via the ‘Save PDF’ action button.

The effects of dietary isohumulones, the main components accounting for the bitter taste of beer, on lipid metabolism were examined. Young female C57BL/6N mice were fed diets containing isomerized hop extract (IHE), which consists mainly of isohumulones. Administration of IHE with an atherogenic (high-fat and high-cholesterol) diet for 2 weeks resulted in a significant increase in plasma HDL-cholesterol (P<0·01), along with a concomitant reduction in the atherosclerosis index, an increase in liver weight and a decrease in body weight gain in a dose-dependent manner. When animals received IHE with either a cholesterol or a basal diet for 1 week, significant decreases in the liver content of cholesterol (P<0·01) and triacylglycerol (cholesterol diet, P<0·01) were observed. Quantitative analyses of hepatic mRNA levels revealed that IHE administration resulted in up-regulation of mRNA for acyl-CoA oxidase, acyl-CoA synthetase, hydroxymethylglutaryl-CoA synthetase, lipoprotein lipase and fatty acid transport protein, and down-regulation of mRNA for Apo CIII and Apo AI. Administration of purified isohumulones effectively resulted in the same changes as IHE. Administration of fenofibrate, an agonist for PPARα, with a cholesterol diet caused marked hepatomegaly, an increase in plasma HDL-cholesterol, a decrease in hepatic cholesterol content, and alterations in hepatic mRNA levels similar to those observed in mice given IHE. Taken together, these results suggest that the modulation of lipid metabolism observed in mice fed diets containing isohumulones is, at least in part, mediated by activation of PPARα.

Research Article
Copyright © The Nutrition Society 2005


Aalto-Setälä, K, Fisher, EA, Chen, X, Chajek-Shaul, T, Hayek, T, Zechner, R, Walsh, A, Ramakrishnan, R, Ginsberg, HN & Breslow, JL (1992) Mechanism of hypertriglyceridemia in human apolipoprotein (Apo) CIII transgenic mice. Diminished very low density lipoprotein fraction catabolic rate associated with increased Apo CIII and reduced Apo E on the particles. J Clin Invest 90, 18891900.CrossRefGoogle Scholar
American Institute of Nutrition (1977) Report of the American Institute of Nutrition ad hoc writing committee on standard diets for nutritional studies. J Nutr 107, 13401348.CrossRefGoogle Scholar
Berthou, L, Duverger, N & Emmanuel, F, et al. (1996) Opposite regulation of human versus mouse apolipoprotein A-1 by fibrates in human apolipoprotein A-1 transgenic mice. J Clin Invest 97, 24082416.CrossRefGoogle ScholarPubMed
Brenner, H, Rothenbacher, D, Bode, G, März, W, Hoffmeister, A & Koenig, W (2001) Coronary heart disease risk reduction in a predominantly beer-drinking population. Epidemiology 12, 390395.CrossRefGoogle Scholar
Carr, TP, Andresen, CJ & Rudel, LL (1993) Enzymatic determination of triglyderide, free cholesterol, and total cholesterol in tissue lipid extracts. Clin Biochem 26, 3942.CrossRefGoogle Scholar
Cripui, MH & Ringel, BL (1994) Does diet or alcohol explain the French paradox? Lancet 344, 17191723.Google Scholar
Doll, R, Peto, R, Hall, E, Wheatley, K & Gray, R (1994) Mortality in relation to consumption of alcohol: 13 years' observations on male British doctors. Br Med J 309, 911918.CrossRefGoogle ScholarPubMed
Fruchart, JC (2001) Peroxisome proliferator-activated receptor-α activation and high-density lipoprotein metabolism. Am J Cardiol 88 24N – 29NCrossRefGoogle ScholarPubMed
Fuchs, CS, Stampfer, MJ, Colditz, GA, Giovannucci, EL, Manson, JE & Kawachi, I (1995) Alcohol consumption and mortality among women. N Engl J Med 322, 12451250.CrossRefGoogle Scholar
Gaziano, JM, Gaziano, TA & Glynn, RJ (2000) Light-to-moderate alcohol consumption and mortality in the Physicians' Health Study. J Am Coll Cardiol 35, 96105.CrossRefGoogle ScholarPubMed
Guerre-Millo, M, Gervois, P, Raspé, E, et al. (2000) Peroxisome proliferator-activated receptor α activators improve insulin sensitivity and reduce adiposity. J Biol Chem 275, 1663816642.CrossRefGoogle ScholarPubMed
Guo, Q, Wang, PR, Milot, DP, Ippolito, MC, Hernandez, M, Burton, CA, Wright, SD & Chao, Y (2001) Regulation of lipid metabolism and gene expression by fenofibrate in hamsters. Biochim Biophys Acta 1533, 220232.CrossRefGoogle ScholarPubMed
Ha, YC & Barter, PJ (1985) Rapid separation of plasma lipoprotein by gel permeation chromatography on agarose gel Superose 6B. J Chromatogr 341, 154159.CrossRefGoogle ScholarPubMed
Hayek, T, Fuhrman, B, Vaya, J, Rosenblat, M, Belinky, P, Coleman, R, Elis, A & Aviram, M (1997) Reduced progression of atherosclerosis in apolipoprotein E-deficient mice following consumption of red wine, or its polyphenols quercetin or catechin, is associated with reduced susceptibility of LDL to oxidation and aggregation. Atherioscler Thromb Vasc Biol 17, 27442752.CrossRefGoogle ScholarPubMed
Hoffmeister, H, Schelp, FP, Mensink, GB, Dietz, E & Bohning, DR (1999) The relationship between alcohol consumption, health indicators and mortality in the German population. Int J Epidemiol 28, 10661072.CrossRefGoogle ScholarPubMed
Honma, Y, Tobe, H, Makishima, M, Yokoyama, A & Okabe-Kado, J (1998) Induction of differentiation of myelogenous leukemia cells by humulone, a bitter in the hop. Leuk Res 22, 605610.CrossRefGoogle ScholarPubMed
Kersten, S, Desvergne, B & Wahll, W (2000) Roles of PPARs in health and disease. Nature 405, 421424.CrossRefGoogle ScholarPubMed
Mayer, O, Simon, J & Rosolova, H (2001) A population study of the influence of beer consumption on folate and homocysteine concentrations. Eur J Clin Nutr 55, 605609.CrossRefGoogle ScholarPubMed
Mennen, LI, de Courcy, GP, Guilland, JC, Ducros, V, Zarebska, M, Bertrais, S, Favier, A, Hercberg, S & Galan, P (2003) Relation between homocysteine concentrations and the consumption of different types of alcoholic beverages: the French Supplementation with Antioxidant Vitamins and Minerals Study. Am J Clin Nutr 78, 334338.CrossRefGoogle ScholarPubMed
Miranda, CL, Stevens, JF, Helmrich, A, Henderson, MC & Rodriguez, RJ (1993) Commonly occurring plant flavonoids have estrogenic activity. Mol Pharmacol 44, 3743.Google Scholar
Mizobuchi, S & Sato, Y (1984) A new flavanone with antifungal activity isolated from hops. Agric Biol Chem 48, 2771–2275.Google Scholar
Mizobuchi, S & Sato, Y (1985) Antifungal activity of hop bitter resins and related compounds. Agric Biol Chem 49, 399403.Google Scholar
Nigdikar, SV, Williams, NR, Griffin, BA & Howard, AN (1998) Consumption of red wine polyphenols reduces the susceptibility of LDL to oxidation in vivo. Am J Clin Nutr 68, 258265.CrossRefGoogle ScholarPubMed
Nishina, PM, Verstuyft, J & Painen, B (1990) Synthetic low and high fat diets for the study of atherosclerosis in the mouse. J Lipid Res 31, 859869.Google Scholar
Nishina, PM, Wang, J, Toyofuku, W, Kuypers, FA, Ishida, BY & Painen, B (1993) Atherosclerosis and plasma and liver lipids in nine inbred strains of mice. Lipids 28, 599605.CrossRefGoogle ScholarPubMed
Oliver, P, Plancke, MO, Marzin, D, Clavey, V, Sauzieres, J & Fruchart, JC (1988) Effects of fenofibrate, gemfibrozil and nicotinic acid on plasma lipoprotein levels in normal and hyperlipidemic mice. Atherosclerosis 70, 107114.CrossRefGoogle Scholar
Petit, D, Bonnefis, MT & Infante, R (1988) Effects of ciprofibrate and fenofibrate on liver lipids and lipoprotein synthesis in normo- and hyperlipidemic rats. Atherosclerosis 74, 22152241.CrossRefGoogle ScholarPubMed
Reddy, JK, Goel, SK, Nemali, MR, Carrino, JJ, Laffler, TG, Reddy, MK, Sperbeck, SJ, Osumi, T, Hashimoto, T & Lalwani, ND (1986) Transcription regulation of peroxisomal fatty acyl-CoA oxidese and enoyl-CoA hydratase/3-hydroxyacyl-CoA dehydrogenase in rat liver by peroxisome proliferators. Proc Natl Acad Sci USA 83, 17471751.CrossRefGoogle Scholar
Reeves, PG, Nielsen, FH & Fahey, GC (1993) AIN-93 purified diets for laboratory rodents: final report of the American Institute of Nutrition ad hoc writing on the reformation of the AIN-76 rodent diet. J Nutr 123, 19391951.CrossRefGoogle Scholar
Renaud, S, de Lorgeril, M (1992) Wine, alcohol, platelets, and the French paradox for coronary heart disease. Lancet 339, 15231526.CrossRefGoogle ScholarPubMed
Schoonjans, K, Staels, B & Auwerx, J (1996a) Role of the peroxisome proliferator-activated receptors (PPAR) in mediating the effects of fibrates and fatty acids on gene expression. J Lipid Res 37, 907925.Google ScholarPubMed
Schoonjans, K, Staels, B & Auwerx, J (1996b) The peroxisome proliferator-activated receptor (PPAR) and their effects on lipid metabolism and adipocyte differentiation. Biochim Biophys Acta 1302, 92109.Google ScholarPubMed
Sehayek, E & Eisenberg, S (1991) Mechanisms of inhibition by apolipoprotein C of apolipoprotein E-dependent cellular metabolism of human triglyceride-rich lipoproteins through the low density lipoprotein receptor pathway. J Biol Chem 270, 1825918267.Google Scholar
Shimamura, M, Hazato, T, Ashino, H, Yamamoto, Y, Iwasaki, E, Tobe, H, Yamamoto, K & Yamamoto, S (2001) Inhibition of angiogenesis by humulone, a bitter acid from beer hop. Biochem Biophys Res Commun 289, 220224.CrossRefGoogle ScholarPubMed
Suh, I, Shaten, BJ, Culter, JA & Kuller, LH (1992) Alcohol use and mortality from coronary artery disease: the role of high-density lipoprotein cholesterol. The Multiple Risk Factor Intervention Trial Research Group. Ann Intern Med 116, 881887.CrossRefGoogle Scholar
Tobe, H, Kubota, M, Yamaguchi, M, Kocha, T & Aoyagi, T (1997a) Apoptosis to HL-60 by humulone. Biosci Biotechnol Biochem 61, 10271029.CrossRefGoogle ScholarPubMed
Tobe, H, Muraki, Y, Kitamura, K, Komiyama, O, Sato, Y, Sugioka, T, Maruyama, HB, Matsuda, E & Nagai, M (1997b) Bone resorption inhibitors from hop extract. Biosci Biotechnol Biochem 61, 158159.CrossRefGoogle ScholarPubMed
Van der Gaag, MS, Ubbink, JB, Sillanaukee, P, Nikkari, S & Hendriks, HF (2000) Effect of consumption of red wine, spirits, and beer on serum homocysteine. Lancet 355, 1522.CrossRefGoogle ScholarPubMed
Wang, PR, Guo, Q, Ippolito, M, Wu, M, Milot, D, Ventre, J, Doebber, T, Wright, SD & Chao, YS (2001) High fat fed hamster, a unique animal model for treatment of diabetic dyslipidemia with peroxisome proliferator activated receptor α selective agonist. Eur J Pharmacol 427, 285293.CrossRefGoogle Scholar
Yajima, H, Ikeshima, E, Shiraki, M, Kanaya, T, Fujiwara, D, Odai, H, Tsuboyama-Kasaoka, N, Ezaki, O, Oikawa, S & Kondo, K (2004) Isohumulones, bitter acids derived from hops, activate both peroxisome proliferators-activated receptor α and γ and reduce insulin resistance. J Biol Chem 279, 3345633462.CrossRefGoogle Scholar
Yamamoto, K, Wang, J, Yamamoto, S & Tobe, H (2000) Suppression of cyclooxygenase-2 gene transcription by humulon of beer hop extract studied with reference to glucocorticoid. FEBS Lett 465, 103106.CrossRefGoogle ScholarPubMed
Yasukawa, K, Takeuchi, M & Takido, M (1995) Humulon, a bitter in the hop, inhibits tumor promotion by 12- O -tetradecanoylphorbol-13-acetate in two-stage carcinogenesis in mouse skin. Oncology 52, 156158.CrossRefGoogle ScholarPubMed